Finding studies
Finding studies
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Suchit D Kumbhare
CONTACT
Suresh O
CONTACT
Lead
Aurigene Discovery Technologies Limited
The main objective of Part 1 will be to evaluate the safety and tolerability of the study drug AUR112. Dose escalation of single agent AUR112 will be conducted in the classic 3+3 design. Safety including Dose Limiting Toxicities (DLTs), PK, and PD will be assessed at each dose. Dose escalation will continue until safety limits are reached or the escalation will stop earlier if PK/PD data suggest that a biologically active dose has reached. The objective is to determine dose(s) which will be investigated in future trials.
Age
18–99
Sex
ALL
Healthy volunteers
Not accepted